TRETINOIN FOR THE TREATMENT OF CUTANEOUS GRAFT-VERSUS-HOST DISEASE

被引:0
|
作者
GRYN, J
CRILLEY, P
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:279 / 280
页数:2
相关论文
共 50 条
  • [31] The Treatment of Chronic Graft-Versus-Host Disease
    Wolff, Daniel
    Bertz, Hartmut
    Greinix, Hildegard
    Lawitschka, Anita
    Halter, Joerg
    Holler, Ernst
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (43): : 732 - I
  • [32] Treatment options for graft-versus-host disease
    Hilgendorf, Inken
    Wolff, Daniel
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (09): : 731 - 743
  • [33] THALIDOMIDE IN THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
    HENEY, D
    BAILEY, CC
    LEWIS, IJ
    BIOMEDICINE & PHARMACOTHERAPY, 1990, 44 (04) : 199 - 204
  • [34] Ruxolitinib for treatment of Graft-versus-Host Disease
    Krueger, W. H.
    Neumann, T.
    Weigel, M.
    Plis, A.
    Schneidewind, L.
    Vaizian, R.
    Schmidt, C. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 70 - 71
  • [35] Pathophysiology and treatment of graft-versus-host disease
    Flowers, MED
    Kansu, E
    Sullivan, KM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 1091 - +
  • [36] Treatment of graft-versus-host disease with photopheresis
    Dall'Amico, R
    Zacchello, G
    TRANSPLANTATION, 1998, 65 (09) : 1283 - 1284
  • [37] Prevention and treatment of graft-versus-host disease
    Chao, NJ
    Schlegel, PG
    BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY, 1995, 770 : 130 - 140
  • [38] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [39] Advances in the treatment of graft-versus-host disease
    GB Vogelsang
    Leukemia, 2000, 14 : 509 - 510
  • [40] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949